Lercanidipine hydrochloride
Lernidum contains the active substance lercanidipine hydrochloride, which belongs to a group of so-called calcium antagonists (dihydropyridine derivatives) - drugs that lower blood pressure. This medicine is used to treat high blood pressure (hypertension) in adults.
Treatment of mild to moderate essential hypertension in adults.
Do not take this medicine if you are pregnant or breastfeeding (see section "Pregnancy, breastfeeding and fertility").
Before taking Lernidum, discuss it with your doctor or pharmacist if you:
If you are pregnant (or think you may be pregnant) or are breastfeeding, tell your doctor (see section "Pregnancy, breastfeeding and fertility").
Do not use this medicine in children and adolescents under 18 years of age, as the safety and efficacy of lercanidipine have not been established due to lack of available data.
Tell your doctor or pharmacist about all medicines you are taking now or have recently taken, as well as any medicines you plan to take, especially if you are taking:
your doctorbefore taking the medicine.
During treatment, do not:
If you are pregnant or breastfeeding, or think you may be pregnant or are planning to have a baby, do not take Lernidum.
Women of childbearing age should use effective contraception while taking Lernidum. If you become pregnant during treatment, tell your doctor immediately, who will decide on further treatment.
Lernidum does not have a significant effect on the ability to drive or use machines, but side effects such as dizziness, weakness, fatigue, and rarely - drowsiness may occur. Be cautious and do not drive or use machines until you know how the medicine affects you.
Lernidum, 10 mg contains 0.928 mg of sodium per tablet.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is considered "sodium-free".
Lernidum, 20 mg contains 1.437 mg of sodium per tablet.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is considered "sodium-free".
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The recommended dose is 10 mg (1 tablet) once daily, taken at the same time every day, preferably in the morning, at least 15 minutes before breakfast.
If necessary, your doctor may increase the dose to 20 mg (1 tablet) once daily.
Swallow the tablets whole with water.
The score line on the Lernidum, 10 mg tablet is only to facilitate breaking the tablet to make it easier to swallow, and not to divide it into equal doses.
The Lernidum, 20 mg tablet can be divided into equal doses.
No dose adjustment is necessary, but be cautious when starting treatment.
Be cautious when starting treatment and when increasing the dose to 20 mg once daily.
Do not use this medicine in children and adolescents under 18 years of age.
Do not take a higher dose than recommended.
If you have taken a higher dose than recommended or have taken an overdose, seek medical attention immediately and, if possible, take the remaining tablets and/or packaging with you.
Taking a higher dose than recommended may cause excessive lowering of blood pressure and irregular or rapid heart rate, which can also lead to loss of consciousness.
If you forget to take a dose, skip the missed dose and take the next tablet at the usual time the next day. Do not take a double dose to make up for the missed dose.
If you stop taking the medicine, your blood pressure may rise again. Before stopping the medicine, consult your doctor.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Lernidum can cause side effects, although not everybody gets them.
You should immediatelystop taking this medicine and contact your doctor or go to the emergency department of the nearest hospital if you experience:
In patients with angina, the use of medicines from the same group as Lernidum may increase the frequency, duration or severity of pain attacks. Isolated cases of heart attack have been observed.
Common (may occur in less than 1 in 10 people):
Uncommon (may occur in less than 1 in 100 people):
Rare (may occur in less than 1 in 1000 people):
Frequency not known (cannot be estimated from the available data):
If you experience any side effects, including those not listed in this leaflet, tell your doctor, pharmacist or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products:
Aleje Jerozolimskie 181C, 02-222 Warsaw
Phone: +48 22 49 21 301;
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister after EXP. The expiry date refers to the last day of the month.
Lernidum, 10 mg
Store in the original packaging to protect from light.
Lernidum, 20 mg
Store below 30°C.
Store in the original packaging to protect from light.
Batch - means batch number.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Lernidum, 10 mg
The active substance is lercanidipine hydrochloride.
Each coated tablet contains 10 mg of lercanidipine hydrochloride, equivalent to 9.4 mg of lercanidipine.
The other ingredients are:
Core: corn starch, sodium carboxymethylcellulose (type A), colloidal anhydrous silica, microcrystalline cellulose, poloxamer 188, sodium stearyl fumarate, macrogol 6000.
Coating: hypromellose 6cps, macrogol 6000, yellow iron oxide (E 172), titanium dioxide (E 171).
Lernidum, 20 mg
The active substance is lercanidipine hydrochloride.
Each coated tablet contains 20 mg of lercanidipine hydrochloride, equivalent to 18.8 mg of lercanidipine.
The other ingredients are:
Core: microcrystalline cellulose, corn starch, sodium carboxymethylcellulose (type A), colloidal anhydrous silica, povidone K-30, sodium stearyl fumarate.
Coating: hypromellose 6cps, macrogol 6000, red iron oxide (E 172), titanium dioxide (E 171).
Lernidum, 10 mg is a yellow, round, biconvex coated tablet with a score line on one side and a smooth surface on the other, approximately 6.5 mm x 3.3 mm in size.
Lernidum, 10 mg is packaged in blisters. One pack contains: 10, 14, 28 or 56 coated tablets in a carton.
Lernidum, 20 mg is a pink, round, biconvex coated tablet with a score line on one side and a smooth surface on the other, approximately 8.5 mm x 4.0 mm in size.
Lernidum, 20 mg is packaged in blisters. One pack contains: 10, 14, 28 or 56 coated tablets in a carton.
Not all pack sizes may be marketed.
Aflofarm Farmacja Polska Sp. z o.o.
ul. Partyzancka 133/151,
95-200 Pabianice
Phone: (42) 22-53-100
Aflofarm Farmacja Polska Sp. z o.o.
ul. Szkolna 31,
95-054 Ksawerów
Poland
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.